|
2026
|
Invention
|
Immunogenic pharmaceutical compositions. An immunogenic pharmaceutical composition comprising: a)... |
|
2025
|
Invention
|
Novel molecules for therapy and diagnosis.
The present invention relates to novel molecules that... |
|
|
Invention
|
Heterocyclic compounds modulating the nlrp3 inflammasome pathway. The present invention relates t... |
|
|
Invention
|
Compounds for use as neuroprotective agents and/or in inhibiting formation of alpha-synuclein agg... |
|
|
Invention
|
Therapeutic use of nlrp3 inflammasome pathway inhibitor compounds. The present invention relates ... |
|
|
Invention
|
2,4-dihydropyrazolo[3',4':4,5]pyrano[2,3-b]pyridine compounds. Novel and useful compounds, such a... |
|
|
Invention
|
Fusion protein peptide linkers and uses thereof. inter aliainter alia, promote the solubility, ex... |
|
|
Invention
|
Anti-tdp-43 vectors, binding molecules and uses thereof. The present invention is in the field of... |
|
|
Invention
|
Compositions of phosphorylated tau peptides and uses thereof.
Liposomes containing tau peptides,... |
|
|
Invention
|
Method of safe administration of phosphorylated tau peptide vaccine.
Methods for inducing anti-p... |
|
|
Invention
|
Novel compounds for the diagnosis of tdp-43 proteinopathies. The present invention relates to com... |
|
|
Invention
|
Thiazolo[5,4-c]pyridine-4(5h)-one derivatives for the diagnosis of tdp-43 proteinopathies. The pr... |
|
|
Invention
|
Immunoassay involving antibodies binding vaccine adjuvants. Provided herein are assays and method... |
|
|
Invention
|
Vectorized anti-tdp-43 antibodies. The present invention is in the field of AAV vectorized TDP-43... |
|
|
Invention
|
Alpha synuclein therapeutic vaccine. The present invention relates to immunogenic compositions th... |
|
|
Invention
|
Novel compounds. The present invention relates to novel compounds for the treatment, alleviation ... |
|
|
Invention
|
Imidazo[1,2-d][1,2,4]triazine derivatives for use as inhibitors of the nlrp3 inflammasome pathway... |
|
|
Invention
|
Liposomes containing phosphorylated tau peptides for inducing sustained immune responses.
Method... |
|
2024
|
Invention
|
Heterocyclic modulators of the nlrp3 inflammasome pathway. The present application relates to com... |
|
|
Invention
|
Antibody drug conjugates targeting proteinopathies, and uses thereof. The invention provides anti... |
|
|
Invention
|
Assays and methods for assessing vaccine preparations. Provided herein are assays and methods of ... |
|
|
Invention
|
Tau active functional assays. The application describes methods for evaluating the capacity of an... |
|
|
Invention
|
Method of treating preclinicial alzheimer's disease. The application describes a phosphorylated t... |
|
|
Invention
|
Method of treating preclinicial alzheimer's disease.
The application describes a phosphorylated ... |
|
|
Invention
|
Diagnostic compounds that bind to alpha-synuclein. The present application relates to novel compo... |
|
|
Invention
|
Novel compounds for the treatment of disease associated with alpha-synuclein aggregates. The pres... |
|
|
Invention
|
Novel compounds for the treatment of disease associated with alpha-synuclein aggregates |
|
|
Invention
|
Anti-abeta therapeutic vaccines.
A liposomal vaccine composition comprises a β-amyloid (Aβ)-deri... |
|
|
Invention
|
Anti-tdp-43 binding molecules and uses thereof. The present invention is in the field of transact... |
|
2023
|
Invention
|
Vaccine therapy.
The present invention provides means for treating, alleviating and preventing a... |
|
|
Invention
|
Novel compounds for diagnosis.
The present invention relates to novel compounds of formula (I), ... |
|
|
Invention
|
Novel compounds for the diagnosis of tdp-43 proteinopathies.
The present invention relates to co... |
|
|
Invention
|
Anti-tdp-43 binding molecules.
TDP-43 binding molecules specifically binding phosphorylated TDP-... |
|
|
Invention
|
Humanized anti-tdp-43 binding molecules and uses thereof.
The present invention is in the field ... |
|
|
Invention
|
Anti-alpha-synuclein therapeutic vaccines.
The present invention relates to a liposomal vaccine ... |
|
2022
|
Invention
|
Dihydro-oxazol derivative compounds.
The present invention relates to novel compounds for the tr... |
|
|
Invention
|
Novel molecules for therapy and diagnosis.
The present invention is in the field of the adaptor ... |
|
|
Invention
|
Dihydropyrrolo[3,4-c]pyrazole derivatives and their use in diagnosis.
The present invention rela... |
|
|
Invention
|
Dihydropyrrolo[3,4c]-pyrazole derivatives and their use in diagnosis.
The present invention rela... |
|
|
Invention
|
4h-imidazo[1,5-b]pyrazole derivatives for diagnosis.
The present invention relates to novel comp... |
|
|
Invention
|
Method of safe administration of tau phosphopeptide conjugate.
Methods for inducing anti-phospho... |
|
2021
|
Invention
|
Antibodies binding to alpha-synuclein for therapy and diagnosis.
The present invention relates t... |
|
2020
|
Invention
|
Novel molecules for therapy and diagnosis.
The present invention relates to biparatopic antigen-... |
|
2019
|
P/S
|
Chemicals for use in industry and science; chemical substances, chemical materials and chemical p... |
|
|
P/S
|
Antibody reagents for scientific purposes; cell culture reagents for laboratory use; cell culture... |
|
|
P/S
|
Diagnostic biomarkers for in vitro testing for scientific use, biological assays and kits for use... |
|
|
P/S
|
Antibody reagents for scientific purposes, cell culture reagents for laboratory use, cell culture... |
|
2018
|
Invention
|
Compositions of phosphorylated tau peptides and uses thereof. Liposomes containing tau peptides, ... |
|
2016
|
Invention
|
Anti-tau antibodies and methods of use. The invention provides anti-Tau antibodies and methods of... |
|
2006
|
P/S
|
Chemical and biological preparations for use in industry,
science and laboratories. chemical pre... |
|
|
P/S
|
Chemical and biological preparations for use in industry,
science and laboratories. Pharmaceutic... |
